1 citations
,
November 2023 This study examined the prevalence and management of PCOD, finding that it primarily affects unmarried women aged 18-25, causing symptoms like irregular periods and infertility, with many opting for medication and lifestyle changes despite mixed beliefs about their effectiveness.
1 citations
,
April 2022 in “International journal of Ayurveda and pharma research” This case study reports on an Ayurvedic treatment approach for a 22-year-old woman with Polycystic Ovarian Disease showing symptomatic relief and improvements in ultrasound findings.
August 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, a 26-year-old woman with polycystic ovarian disease and advanced hair loss (Ludwig Grade III) showed reduced hair shedding and improved hair density after four sessions of platelet-rich plasma combined with microneedling, with no reported adverse effects.
August 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, a 26-year-old woman with polycystic ovarian disease and severe hair loss showed reduced hair shedding and improved hair density following four sessions of platelet-rich plasma combined with microneedling, with no adverse effects reported.
July 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This article reviews existing strategies for managing polycystic ovarian disease and highlights the role of lifestyle changes, natural remedies, and conventional treatments, reporting no new clinical results.
July 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review covers the diagnosis, complications, and management strategies for Polycystic Ovarian Disease, reporting no new clinical results and highlighting the potential of personalized medicine.
May 2026 in “The Bioscan.” This review explores the potential benefits of using medicinal plants as an alternative or supplementary therapy for improving reproductive and metabolic health in women with polycystic ovary syndrome, but reports no new results.
March 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This report reviews the causes, symptoms, diagnosis, complications, and treatment options for Polycystic Ovarian Disease, emphasizing the importance of early diagnosis and individualized management, but it does not provide new research findings.
March 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This report provides an overview of polycystic ovarian disease, discussing its causes, symptoms, and management strategies, but presents no new clinical findings.
February 2026 in “International Journal on Science and Technology” This review discusses the potential benefits of Vitex negundo for managing polycystic ovarian disease, highlighting its promising effects in animal models, but notes that more rigorous human trials are needed to confirm these findings.
October 2025 in “International Journal of Science and Research (IJSR)” This article reviews the epidemiology, causes, clinical impact, and potential preventive strategies for Polycystic Ovarian Disease but reports no new research findings.
May 2025 in “International Journal of Biology Pharmacy and Allied Sciences” This case study reports that Ayurvedic treatment resulted in significant clinical improvement and reduced ovary size in a 28-year-old woman with PCOD over a 2.5-month period.
April 2025 in “International Journal of Multidisciplinary Research in Science, Engineering and Technology.” In this study, researchers surveyed 100 women with PCOD or PCOS and found no statistical correlation between the diagnosis and common symptoms like irregular menstruation or infertility, suggesting a need for further research with larger samples.
January 2025 in “i-manager s Journal on Life Sciences” This review discusses PCOD's pathophysiology, clinical features, and management strategies but reports no new clinical findings, emphasizing the need for early diagnosis and multidisciplinary management.
December 2024 in “African Journal of Biomedical Research” In this case study, a 32-year-old woman with premenstrual syndrome experienced significant improvement in symptoms such as dyspepsia, facial hair growth, and weight gain through Ayurvedic treatment, demonstrating its potential to address irregular menstruation effectively.
April 2024 in “International Journal of Advanced Research in Science Communication and Technology” This review explores the impact of synthetic and herbal drugs on hormone levels and ovarian tissue in PCOD but reports no new clinical findings.
August 2023 in “International Journal For Multidisciplinary Research” This case study reported that using the ayurvedic treatment protocol of Nitya Virechana, Kulatthadi Kashaya, and Shatapushpa Churna was associated with improved menstrual regularity, reduced obesity, and decreased symptoms of hirsutism and acne in a 19-year-old woman with PCOD.
October 2022 in “Indian Journal of Pharmacy Practice” This article discusses the confusion and misinformation surrounding PCOD and PCOS, two distinct but commonly misunderstood conditions, and reports no new clinical results.
September 2022 in “Journal of Contemporary medical practice” This study found that among women with polycystic ovarian disease, 72% experienced infertility, indicating a correlation between PCOD and difficulties in conceiving.
This review outlines acne management strategies for individuals with polycystic ovary syndrome, but reports no new clinical results.
January 2024 in “International Journal of Biological and Environmental Investigations” This study found that female students aged 18-21 with PCOS had higher weight compared to those without, though their BMI remained in the normal range.
April 2022 in “International Journal of Science and Research (IJSR)” This study found a correlation between polycystic ovarian disease and infertility among women, with 72% of participants experiencing difficulty conceiving.
August 2018 in “Ayurlog: national journal of research in ayurveda science” This study reviewed Ayurvedic and modern texts to identify methods for managing PCOD through Ayurvedic dietary practices, proposing that these may help address symptoms by improving metabolic and endocrine functions without specific experimental results reported.
29 citations
,
January 1998 in “Dermatology” This research reports that many acne patients have elevated androgen levels, contributing to a cycle that may lead to polycystic ovarian disease and potentially sterility.
20 citations
,
December 1994 in “Fertility and sterility” In this study, treatment with flutamide combined with a low-dose oral contraceptive significantly improved hirsutism in women with polycystic ovarian disease who did not respond to oral contraceptive treatment alone.
19 citations
,
March 1994 in “Fertility and sterility” This study found that treatment with a GnRH agonist and estrogen and progestin replacement significantly improved hirsutism scores and hair growth rates in women with polycystic ovarian disease.
4 citations
,
March 2012 in “Our Dermatology Online” This study conducted physical examinations on fifty women with hirsutism, focusing on virilization signs, but reports no new clinical findings.
4 citations
,
January 1989 in “Journal of Steroid Biochemistry” This study suggests that 5-ADIOL-S may contribute to the synthesis of potent androgens in peripheral tissues, and 3 alpha-DIOL-S could be a marker of androgen metabolism in various female patient groups.
3 citations
,
January 2020 in “Indian Dermatology Online Journal” In this study, significant correlations were observed between acanthosis nigricans and factors like free testosterone, DHEAS, fasting blood sugar, and BMI, as well as between hirsutism and elevated DHEAS, free testosterone, and BMI among patients with polycystic ovarian disease.
1 citations
,
February 2025 in “Journal of Pharma Insights and Research.” This analysis explores the potential benefits of various nutraceuticals, such as Ashwagandha, Cinnamon, and Fenugreek, in managing Polycystic Ovarian Disease, suggesting these may improve menstrual regularity, insulin sensitivity, and other symptoms when used alongside conventional treatments.